{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:18:16Z","timestamp":1790716696392,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.lfs.2016.01.013","type":"journal-article","created":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T12:34:11Z","timestamp":1452515651000},"page":"66-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Evidence that diclofenac and celecoxib are thyroid hormone receptor beta antagonists"],"prefix":"10.1016","volume":"146","author":[{"given":"Mire","family":"Zloh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelia","family":"Perez-Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7872-041X","authenticated-orcid":false,"given":"Leslie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pryank","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise S.","family":"Mackenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.lfs.2016.01.013_bb0005","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0090-6980(76)90048-4","article-title":"A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation","volume":"12","author":"Moncada","year":"1976","journal-title":"Prostaglandins"},{"issue":"1","key":"10.1016\/j.lfs.2016.01.013_bb0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nrd1929","article-title":"COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs","volume":"5","author":"Mitchell","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9608","key":"10.1016\/j.lfs.2016.01.013_bb0015","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0140-6736(08)60137-3","article-title":"COX-2 selectivity alone does not define the cardiovascular risks associated with non-steroidal anti-inflammatory drugs","volume":"371","author":"Warner","year":"2008","journal-title":"Lancet"},{"issue":"5567","key":"10.1016\/j.lfs.2016.01.013_bb0020","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1126\/science.1068711","article-title":"Role of prostacyclin in the cardiovascular response to thromboxane A2","volume":"296","author":"Cheng","year":"2002","journal-title":"Science"},{"issue":"43","key":"10.1016\/j.lfs.2016.01.013_bb0025","doi-asserted-by":"crossref","first-page":"17597","DOI":"10.1073\/pnas.1209192109","article-title":"Cyclooxygenase-1, not cyclooxygenase-2, is responsible for physiological production of prostacyclin in the cardiovascular system","volume":"109","author":"Kirkby","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.lfs.2016.01.013_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069524","article-title":"LC\u2013MS\/MS confirms that COX-1 drives vascular prostacyclin whilst gene expression pattern reveals non-vascular sites of COX-2 expression","volume":"8","author":"Kirkby","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.lfs.2016.01.013_bb0035","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/CIRCULATIONAHA.114.011591","article-title":"Evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs","volume":"131","author":"Ahmetaj-Shala","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2016.01.013_bb0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000360558","article-title":"Cardiovascular disease and thyroid function","volume":"43","author":"Faber","year":"2014","journal-title":"Front. Horm. Res."},{"issue":"2","key":"10.1016\/j.lfs.2016.01.013_bb0045","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.toxlet.2014.09.004","article-title":"OpenVirtualToxLab\u2014a platform for generating and exchanging in silico toxicity data","volume":"232","author":"Vedani","year":"2015","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.lfs.2016.01.013_bb0050","doi-asserted-by":"crossref","first-page":"W609","DOI":"10.1093\/nar\/gkq300","article-title":"PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach","volume":"38","author":"Liu","year":"2010","journal-title":"Nucleic. Acids Res."},{"key":"10.1016\/j.lfs.2016.01.013_bb0055","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/(SICI)1096-987X(19961115)17:14<1653::AID-JCC7>3.0.CO;2-K","article-title":"A fast method of molecular shape comparison: a simple application of a Gaussian description of molecular shape","volume":"17","author":"Grant","year":"1996","journal-title":"J. Comput. Chem"},{"key":"10.1016\/j.lfs.2016.01.013_bb0060","unstructured":"Openeye Scientific Software, Santa Fe, New Mexico, http:\/\/www.eyesopen.com\/rocs."},{"issue":"2","key":"10.1016\/j.lfs.2016.01.013_bb0065","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1747-0285.2006.00341.x","article-title":"The use of three-dimensional shape and electrostatic similarity searching in the identification of a melanin-concentrating hormone receptor 1 antagonist","volume":"67","author":"Muchmore","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.lfs.2016.01.013_bb0070","unstructured":"Openeye Scientific Software, Santa Fe, New Mexico, http:\/\/www.eyesopen.com\/eon."},{"issue":"4","key":"10.1016\/j.lfs.2016.01.013_bb0075","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1021\/ci100031x","article-title":"Conformer generation with OMEGA: algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database","volume":"50","author":"Hawkins","year":"2010","journal-title":"J. Chem. Inf. Model."},{"issue":"11","key":"10.1016\/j.lfs.2016.01.013_bb0080","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1021\/ci300314k","article-title":"Conformer generation with OMEGA: learning from the data set and the analysis of failures","volume":"52","author":"Hawkins","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.lfs.2016.01.013_bb0085","unstructured":"Openeye Scientific Software, Santa Fe, New Mexico, http:\/\/www.eyesopen.com\/omega."},{"issue":"12","key":"10.1016\/j.lfs.2016.01.013_bb0090","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1016\/j.bbamcr.2013.08.005","article-title":"Linking phospholipase C isoforms with differentiation function in human vascular smooth muscle cells","volume":"1833","author":"Mackenzie","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.lfs.2016.01.013_bb0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/01.RES.41.1.19","article-title":"Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats","volume":"41","author":"Mulvany","year":"1977","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.lfs.2016.01.013_bb0100","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/thy.1996.6.505","article-title":"Acute effects of thyroid hormone on vascular smooth muscle","volume":"6","author":"Ojamaa","year":"1996","journal-title":"Thyroid"},{"issue":"4","key":"10.1016\/j.lfs.2016.01.013_bb0105","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1213\/00000539-199710000-00005","article-title":"The direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance arteries","volume":"85","author":"Park","year":"1997","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.lfs.2016.01.013_bb0110","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejphar.2014.11.036","article-title":"Thyroid hormone affects both endothelial and vascular smooth muscle cells in rat arteries","volume":"747","author":"Cai","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"38","key":"10.1016\/j.lfs.2016.01.013_bb0115","doi-asserted-by":"crossref","first-page":"14104","DOI":"10.1073\/pnas.0601600103","article-title":"Rapid nongenomic actions of thyroid hormone","volume":"103","author":"Hiroi","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6803","key":"10.1016\/j.lfs.2016.01.013_bb0120","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/35035131","article-title":"Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase","volume":"407","author":"Simoncini","year":"2000","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.lfs.2016.01.013_bb0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/01.RES.0000025269.60668.0F","article-title":"1alpha,25-dihydroxyvitamin D3 induces vascular smooth muscle cell migration via activation of phosphatidylinositol 3-kinase","volume":"91","author":"Rebsamen","year":"2002","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.lfs.2016.01.013_bb0130","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1124\/jpet.109.159806","article-title":"Endothelium-dependent vasodilator effects of peroxisome proliferator-activated receptor beta agonists via the phosphatidyl-inositol-3 kinase-Akt pathway","volume":"332","author":"Jimenez","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.lfs.2016.01.013_bb0135","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nm0502-473","article-title":"Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase","volume":"8","author":"Hafezi-Moghadam","year":"2002","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.lfs.2016.01.013_bb0140","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1074\/jbc.272.6.3406","article-title":"Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs","volume":"272","author":"Lehmann","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.lfs.2016.01.013_bb0145","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0002-9343(94)90148-1","article-title":"Effects of commonly prescribed nonsteroidal anti-inflammatory drugs on thyroid hormone measurements","volume":"96","author":"Bishnoi","year":"1994","journal-title":"Am. J. Med."},{"issue":"3","key":"10.1016\/j.lfs.2016.01.013_bb0150","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1210\/jcem.86.3.7291","article-title":"Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study","volume":"86","author":"Monzani","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.lfs.2016.01.013_bb0155","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2006-1869","article-title":"The beneficial effect of l-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial","volume":"92","author":"Razvi","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.lfs.2016.01.013_bb0160","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1096\/fj.08-107979","article-title":"COX-1, and not COX-2 activity, regulates airway function: relevance to aspirin-sensitive asthma","volume":"22","author":"Harrington","year":"2008","journal-title":"FASEB J."},{"issue":"11","key":"10.1016\/j.lfs.2016.01.013_bb0165","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/j.1526-4637.2012.01479.x","article-title":"A phase 2 study evaluating the efficacy and safety of a novel, proprietary, nano-formulated, lower dose oral diclofenac","volume":"13","author":"Manvelian","year":"2012","journal-title":"Pain Med."},{"issue":"1","key":"10.1016\/j.lfs.2016.01.013_bb0170","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/bmc.115","article-title":"Investigation of the pharmacokinetics of celecoxib by liquid chromatography-mass spectrometry","volume":"16","author":"Werner","year":"2002","journal-title":"Biomed. Chromatogr."},{"issue":"6","key":"10.1016\/j.lfs.2016.01.013_bb0175","first-page":"281","article-title":"Pharmacokinetics of naproxen after oral administration of two tablet formulations in healthy volunteers","volume":"21","author":"Aarbakke","year":"1983","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"issue":"7","key":"10.1016\/j.lfs.2016.01.013_bb0180","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1111\/j.1476-5381.2009.00459.x","article-title":"Endothelium modulates vasoconstrictor response to prostaglandin I2 in rat mesenteric resistance arteries: interaction between EP1 and TP receptors","volume":"158","author":"Xavier","year":"2009","journal-title":"Br. J. Pharmacol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320516300133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320516300133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T07:42:55Z","timestamp":1567496575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320516300133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":36,"alternative-id":["S0024320516300133"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2016.01.013","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence that diclofenac and celecoxib are thyroid hormone receptor beta antagonists","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2016.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}